Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry
Arthritis Res Ther. 2023 Oct 25;25(1):210.
doi: 10.1186/s13075-023-03194-5.
1 Servicio de Reumatologia, Hospital Universitario Ramon Y CajalInstituto Ramon Y Cajal de Investigacion Sanitaria (IRYCIS), Carretera de Colmenar Viejo Km: 9,100, 28034, Madrid, Spain. martavaleroex@yahoo.es.
2 Health Technology Assessment Agency of Carlos III Institute of Health (ISCIII), Madrid, Spain.
3 Department of Rheumatology, Complejo Hospitalario Universitario A Coruna, A Coruna, Spain.
4 Department of Rheumatology, Hospital Universitario de Burgos, Burgos, Spain.
5 Department of Rheumatology, Hospital General de Granollers, Granollers, Barcelona, Spain.
6 Department of Rheumatology, Hospital Universitario Miguel Servet, Saragossa, Spain.
7 Department of Rheumatology, Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain.
8 Department of Rheumatology, Hospital Universitario Regional de Malaga (Hospital Carlos Haya), Malaga, Spain.
9 Department of Rheumatology, Hospital General Universitario de Valencia, Valencia, Spain.
10 Research Unit of Spanish Society of Rheumatology, Madrid, Spain.
11 Department of Rheumatology, Hospital General Universitario Gregorio MaranonInstituto de Investigacion Sanitaria Gregorio Maranon (IiSGM), Universidad Complutense de Madrid, Madrid, Spain.